Novel Treatments for Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia

This publication has 18 references indexed in Scilit:

• Evaluation of Purinergic Mechanism for the Treatment of Voiding Dysfunction: A Study in Conscious Spinal Cord-injured Rats
  Journal of the Chinese Medical Association, 2007
• GW427353 (Solabegron), a Novel, Selective β3-Adrenergic Receptor Agonist, Evokes Bladder Relaxation and Increases Micturition Reflex Threshold in the Dog
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• Relaxation of Human Detrusor Muscle by Selective Beta-2 and Beta-3 Agonists and Endogenous Catecholamines
  Urology, 2007
• Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder
  JAMA, 2006
• The effects of a new selective β₃‐adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladder
  BJU International, 2006
• Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia
  Urology, 2006
• Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Men With Bladder Outlet Obstruction
  Journal of Urology, 2006
• A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the Bladder
  European Urology, 2006
• A Quantitative Analysis of mRNA Expression of α1 and β-adrenoceptor Subtypes and Their Functional Roles in Human Normal and Obstructed Bladders
  Journal of Urology, 2003
• The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society
  Published by Elsevier ,2003